UMIN ID: UMIN000050758
Registered date:04/04/2024
Development of a Novel Amino Acid PET Probe for Imaging Diagnosis of Early Stage Pancreatic Cancer -Exploratory study of protein expression in pancreatic diseases-
Basic Information
| Recruitment status | Complete: follow-up continuing |
|---|---|
| Health condition(s) or Problem(s) studied | Pancreatic cancer, and other pancreatic diseases |
| Date of first enrollment | 2023/04/01 |
| Target sample size | 70 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Comparison of protein expression degrees in benign pancreatic disease, precancerous lesions, and pancreatic cancer lesions |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | If the research subject or his/her representative refuses the use of the tissue pathology specimen for this research after opting out at National Institutes for Quantum Science and Technology and Kanagawa Cancer Center. |
Related Information
| Primary Sponsor | Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, QST |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, QST |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kana Yamazaki |
| Address | 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan Japan 263-8555 |
| Telephone | 0432063402 |
| yamazaki.kana@qst.go.jp | |
| Affiliation | Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, QST Dept. of Molecular Imaging and Theranostics |
| scientific contact | |
| Name | Kana Yamazaki |
| Address | 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan Japan |
| Telephone | 043-206-3402 |
| yamazkai.kana@qst.go.jp | |
| Affiliation | Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, QST Dept. of Molecular Imaging and Theranostics |